Gain Therapeutics (GANX) Return on Equity [ROE] (2020 - 2026)
Gain Therapeutics (GANX) recorded Return on Equity [ROE] of -158.95% in Q2 2026, up 233.50 percentage points from -392.44% a year earlier but down 28.53 percentage points from the prior quarter.
Powered by 
Analysis
Gain Therapeutics (GANX) Return on Equity [ROE] (2020 - 2026) Analysis & Trends
For FY2025, Gain Therapeutics reported Return on Equity [ROE] of -155.66%, up 49.30 percentage points from FY2024.
- Annual Return on Equity [ROE] has a four-year change of -87.93 percentage points (FY2021 to FY2025).
- Across earlier years, Return on Equity [ROE] came in at -204.95% in FY2024 (-63.38 pp), -141.57% in FY2023 (-76.05 pp), -65.52% in FY2022 (+2.21 pp) and -67.73% in FY2021.
- Quarterly Return on Equity [ROE] has ranged from -403.77% in Q3 2025 to -31.23% in Q3 2021 over the past five years.
- On a year-over-year basis, Return on Equity [ROE] has increased for three consecutive quarters, with an average year-over-year change of +2.22 percentage points over the last eight quarters.
- Peak year-over-year performance for Return on Equity [ROE] in the last five years was a gain of 233.50 percentage points in Q2 2026, against a drop of 197.27 percentage points in Q3 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at -130.42% (Q1 2026), -164.76% (Q4 2025) and -403.77% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | - |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | 31.52% |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | 4.97% |
| 10 | Gain Therapeutics | 54.24 Mn | -5.04 Mn | - | -158.95% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -158.95% |
| Mar 31, 2026 | -130.42% |
| Dec 31, 2025 | -164.76% |
| Sep 30, 2025 | -403.77% |
| Jun 30, 2025 | -392.44% |
| Mar 31, 2025 | -319.03% |
| Dec 31, 2024 | -251.23% |
| Sep 30, 2024 | -206.50% |
| Jun 30, 2024 | -211.48% |
| Mar 31, 2024 | -199.28% |
| Dec 31, 2023 | -223.69% |
| Sep 30, 2023 | -241.19% |
| Jun 30, 2023 | -168.18% |
| Mar 31, 2023 | -114.38% |
| Dec 31, 2022 | -84.69% |
| Sep 30, 2022 | -64.96% |
| Jun 30, 2022 | -55.20% |
| Mar 31, 2022 | -44.15% |
| Dec 31, 2021 | -38.39% |
| Sep 30, 2021 | -31.23% |
API Access
Gain Therapeutics Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=GANX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "GANX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=GANX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();